Another Threat To Gilead Has Emerged

NY AG Eric Schneiderman is investigating insurers' HCV restrictions. Insurers might incur higher benefit pay outs or form coalitions to negotiate steeper discounts from Gilead. Either way HCV prices could be cut further.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.